
The Newsroom
Item 1 of 3

AdventHealth Research Institute Offers Phase II Clinical Trial of Etanercept for Treatment of Blast-Induced Tinnitus
Approximately 1 billion people throughout the world suffer from tinnitus (ringing in the ears), and it is the number one disability of those who serve in the U.S. military. The condition can disrupt...
Item 2 of 3

AdventHealth’s Karen D. Corbin, PhD, RD, Contributed to New American Diabetes Association Consensus Statement on Liver Disease in Diabetes
Item 3 of 3

AdventHealth East Orlando First in Florida to Earn Advanced Foot & Ankle Surgery Certification from DNV
Recent Stories at AdventHealthMD
-
-
Clinical Excellence
Using Genomics and AI to Improve Breast Cancer Risk Assessment and Early Detection
-
Clinical Excellence
New Research Published in New England Journal of Medicine Finds That Adjuvant Pembrolizumab Extends Disease-Free Survival in Muscle-Invasive Urothelial Carcinoma
-
Clinical Excellence
AdventHealth Physician Team Performs Central Florida’s First Immediate Breast Neurotization After Nipple-sparing Mastectomy
-
Clinical Excellence
AdventHealth Celebration is Among First in the State to Offer Non-invasive Histotripsy Treatment for Unresectable Liver Tumors
-
Clinical Excellence
Breast Cancer Survivor Credits AdventHealth Clinic For Giving Her Hope, Saving Her Life
-
Clinical Excellence
AdventHealth Cancer Institute is Among the First in the World to Offer a New Phase II Clinical Trial of a Novel, Customized Precision Immunotherapy for Patients with High-risk Muscle-invasive Urothelial Carcinoma
-
Clinical Excellence
AdventHealth Waterman Introduces Robotic-Assisted Procedure for Early Lung Cancer Detection
-
Clinical Excellence
WFTV’s Greg Warmoth Joins AdventHealth’s Dr. Mark Socinski to Discuss His Cancer Journey — and How He Hopes His Message Will Save Others